Pancreatic, thyroid, and other endocrine cancers

Drug Name

• ABRAXANE
• Active Surveillance: Is it an Appropriate Approach for Thyroid Cancer?
• AFINITOR
• ASCO Guideline Update: Modified FOLFIRINOX Is Preferred as Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma
• AZEDRA
• Cancer Consultation Low in Noncurable Pancreatic Adenocarcinoma
• CAPRELSA
• COMETRIQ
• Cumulative Risk for Thyroid Cancer After Initial Benign Thyroid Biopsy
• Doxorubicin HCl
• Doxorubicin HCl Solution
• FFPE Tissue Specimens Deemed Adequate for Molecular Studies: NCI-SEER
• Fluorouracil
• GEMZAR
• High Response Rate for Patients With High-Grade Neuroendocrine Cancer Receiving Dual Immune Checkpoint Blockade
• INFUGEM
• LENVIMA
• LUTATHERA
• LYSODREN
• Maintenance Olaparib May Delay Progression of BRCA-Related Pancreatic Cancer
• Many Perceive Lack of Choice in Receipt of RAI for Thyroid Cancer
• MEKINIST
• Mitomycin
• NEXAVAR
• Once-Weekly Exenatide Treatment Does Not Increase Risk for Medullary Thyroid Carcinoma
• ONIVYDE
• Pediatric Thyroid Cancer Rates Are Rising, but Some Experts Doubt the Significance
• Phase 3 Study Evaluating Novel Therapy for Pancreatic Cancer Discontinued
• Predicting Benefit From Olaparib Maintenance in Metastatic Pancreatic Cancer: The POLO Trial
• SOMATULINE DEPOT
• SUTENT
• SYNTHROID
• TAFINLAR
• TARCEVA
• THYROGEN
• Thyroid Cancer: Individualized Follow-Up Curtails Unnecessary Tests
• TIROSINT-SOL
• UNITHROID
• VITRAKVI
• VITRAKVI ORAL SOLUTION
• ZANOSAR